TENAX THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TENAX THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $30.00K.
- TENAX THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $544.00K, a 92.38% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $7.14M.
- TENAX THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2013 was -$380.00K, a 151.80% decline from fiscal 2012.
- TENAX THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2012 was $733.63K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $30.00K 10-Q · filed 2026-07-31 | |
| 2015-04-30 | $544.00K 10-K · filed 2017-03-16 | |
| 2014-04-30 | $7.14M 10-K · filed 2017-03-16 | |
| 2013-04-30 | -$380.00K 10-KT · filed 2016-03-14 | |
| 2012-04-30 | $733.63K 10-K · filed 2013-06-26 | |
| 2011-04-30 | -$10.45M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |